Financial Planning for Millennials: Yes, You Can Afford It
Rising Food Prices Give Shoppers Indigestion
Beware the Dangers of Social Media Lifestyle Inflation
Market Close: S&P Hits New High on a Mixed Earnings Day
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.